{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:45Z","timestamp":1790805345887,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T00:00:00Z","timestamp":1399939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10534-014-9743-6","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T12:23:42Z","timestamp":1399897422000},"page":"787-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections"],"prefix":"10.1007","volume":"27","author":[{"given":"Maria Iris","family":"Cassetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fallani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Messori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"key":"9743_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2125.2007.03058.x","volume":"64","author":"JK Aroson","year":"2007","unstructured":"Aroson JK (2007) Old drugs\u2014new uses. Br J Clin Pharmacol 64:563\u2013565","journal-title":"Br J Clin Pharmacol"},{"key":"9743_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0306-3623(96)00419-3","volume":"29","author":"J Bondenson","year":"1997","unstructured":"Bondenson J (1997) The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen Pharmacol 29:127\u2013150","journal-title":"Gen Pharmacol"},{"key":"9743_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.drudis.2012.12.009","volume":"18","author":"D Cavalla","year":"2013","unstructured":"Cavalla D (2013) Predictive methods in drug repurposing: gold mine or just a bigger haystack? Drug Discov Today 18:523\u2013532","journal-title":"Drug Discov Today"},{"key":"9743_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"CR Chong","year":"2007","unstructured":"Chong CR, Sullivan DJ (2007) New uses for old drugs. Nature 448:645\u2013646","journal-title":"Nature"},{"key":"9743_CR5","unstructured":"Clinical Laboratory Standards Institute (CLSI) (2004), National Committee for Clinical Laboratory Standard, Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth International Supplement M100-S14, NCCLS, Wayne, PA, USA"},{"key":"9743_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA (1998) Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1\u201310","journal-title":"Clin Infect Dis"},{"key":"9743_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12272-008-1122-9","volume":"31","author":"S Han","year":"2008","unstructured":"Han S, Kim K, Kim H, Kwon J, Lee YH, Lee CK, Song Y, Ha Lee N, Kim K (2008) Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch Pharm Res 31:67\u201374","journal-title":"Arch Pharm Res"},{"key":"9743_CR8","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/JB.00164-09","volume":"191","author":"SE Jackson-Rosario","year":"2009","unstructured":"Jackson-Rosario SE, Self WT (2009) Inhibition of selenium metabolism in the oral pathogen Treponema denticola. J Bacteriol 191:4035\u20134040","journal-title":"J Bacteriol"},{"key":"9743_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/B917141J","volume":"2","author":"SE Jackson-Rosario","year":"2010","unstructured":"Jackson-Rosario SE, Self WT (2010) Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery. Metallomics 2:112\u2013116","journal-title":"Metallomics"},{"key":"9743_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00775-009-0466-z","volume":"14","author":"SE Jackson-Rosario","year":"2009","unstructured":"Jackson-Rosario SE, Cowarte D, Myers A, Tarrien R, Rodney LL, Scott RA, Self WT (2009) Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au\u2013Se adduct. JBIC 14:507\u2013510","journal-title":"JBIC"},{"key":"9743_CR11","first-page":"930","volume":"78","author":"I Karampela","year":"2012","unstructured":"Karampela I, Poulakou G, Dimopoulus G (2012) Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol 78:930\u2013940","journal-title":"Minerva Anestesiol"},{"key":"9743_CR12","first-page":"1071","volume":"4","author":"AN Kuntz","year":"2007","unstructured":"Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arn\u00e9r ES, Williams DL (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLOS Med 4:1071\u20131086","journal-title":"PLOS Med"},{"key":"9743_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10787-012-0149-1","volume":"20","author":"JM Madeira","year":"2012","unstructured":"Madeira JM, Gibson DL, Kean WF, Klegeris A (2012) The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology 20:297\u2013306","journal-title":"Inflammopharmacology"},{"key":"9743_CR14","first-page":"279","volume":"41","author":"L Messori","year":"2004","unstructured":"Messori L, Marcon G (2004) Gold complexes in the treatment of rheumatoid arthritis. Met Ions Biol Syst 41:279\u2013304","journal-title":"Met Ions Biol Syst"},{"key":"9743_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-827X(99)00019-1","volume":"54","author":"F Novelli","year":"1999","unstructured":"Novelli F, Recine M, Sparatore F, Juliano C (1999) Gold(I) complexes as antimicrobial agents. Il Farmaco 54:232\u2013236","journal-title":"Il Farmaco"},{"key":"9743_CR16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.febslet.2008.02.028","volume":"582","author":"AR Sanella","year":"2008","unstructured":"Sanella AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF, Majori G, Severini C (2008) New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: mechanistic and pharmacological implications. FEBS Lett 582:844\u2013847","journal-title":"FEBS Lett"},{"key":"9743_CR17","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/cr980431o","volume":"99","author":"F Shaw","year":"1999","unstructured":"Shaw F (1999) Gold-based therapeutic agents. Chem Rev 99:2589\u20132600","journal-title":"Chem Rev"},{"key":"9743_CR18","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.01675-12","volume":"57","author":"N Tejman-Yarden","year":"2013","unstructured":"Tejman-Yarden N, Miyamoto Y, Leitsch D, Santini J, Debnath A, Gut J, McKerrow JH, Reed SL, Eckmann L (2013) A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother 57:2029\u20132035","journal-title":"Antimicrob Agents Chemother"},{"key":"9743_CR19","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/1521-3773(20000818)39:16<2931::AID-ANIE2931>3.0.CO;2-W","volume":"39","author":"J Zou","year":"2000","unstructured":"Zou J, Taylor P, Dornan J, Robinson SP, Walkinshaw MD, Sadler PJ (2000) First crystal structure of a medicinally relevant gold protein complex: unexpected binding of [Au(PEt3)]+ to histidine. Angew Chem 39:2931\u20132934","journal-title":"Angew Chem"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-014-9743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-014-9743-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-014-9743-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:11:52Z","timestamp":1559218312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-014-9743-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9743"],"URL":"https:\/\/doi.org\/10.1007\/s10534-014-9743-6","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]}}}